The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Silk Road Medical Inc (SILK) shows that investor sentiment remained same, with the stock’s consolidated last price to $8.71. The Silk Road Medical Inc has recorded 281,849 volume in the after hours trading session. Yahoo Finance discussed the stock recently as it posted Silk Road Medical Names Chas McKhann Chief Executive Officer.
Silk Road Medical Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Medical Devices industry. At the end of the last regular session, the stock closed at $8.71 and fluctuated between $8.94 as its day high and $8.55 as its day low. The current market capitalization of Silk Road Medical Inc is $338.21M. A total of 0.99 million shares were traded on the day, compared to an average of 1.17M shares.
Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, SILK has seen 6 BUY and 1 SELL insider trades, representing the acquisition of 466,329 and the disposition of 1,539 shares. Over the last 12 months, there were 56 BUYs and 46 SELLs from insiders. Insiders purchased 873,238 shares during that period but sold 363,588.
In the most recent transaction, Jones Marie L. sold 656 shares of SILK for 6.61 per share on Oct 27. After the transaction, the CAO and VP, Finance now owns 54,941 company shares. In a previous transaction on Oct 04, Buchanan Lucas W. sold 2,662 shares at 15.22 per share. SILK shares that COO/CFO owns now total 435,848.
Among the insiders who sold shares, Klemz Kevin M disposed of 1,539 shares on Aug 17 at a per-share price of $20.11. This resulted in the EVP/Chief Legal Officer/Sec. holding 38,797 shares of SILK after the transaction. In another insider transaction, Davis Andrew S. sold 6,587 shares at $22.13 per share on Aug 03. Company shares held by the Chief Commercial Officer now total 109,534.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for SILK in the last 3 months, the mean price target is $14.63 with high estimates of $30.00 and low estimates of $8.00. In terms of 52-week highs and lows, SILK has a high of $58.04 and a low of $6.08.
As of this writing, SILK has an earnings estimate of -$0.35 per share for the current quarter. EPS was calculated based on a consensus of 9 estimates, with a high estimate of -$0.28 per share and a lower estimate of -$0.43. The company reported an EPS of -$0.43 in the last quarter, which was -10.30% lower than expectations of -$0.39.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. SILK’s latest balance sheet shows that the firm has $110.23M in Cash & Short Term Investments as of fiscal 2021. There were $48.69M in debt and $26.09M in liabilities at the time. Its Book Value Per Share was $4.01, while its Total Shareholder’s Equity was $79.24M.
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SILK is Buy with a score of 2.90.